PINK:MRZM

Marizyme Stock Insider Trading

etoro logo Buy MRZM
*Your capital is at risk
$0.0003
+0 (+0%)
At Close: Jun 03, 2026

Marizyme Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 17.73M and sold 13.3M MRZM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 17.73M shares
Sell 13.3M shares
84% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2022
Buy
Common Stock
J-Other
Stewart Michael R
Director 0
Value: $0
Jun 01, 2022
Buy
Common Stock
J-Other
Stewart Michael R
Director 0
Value: $0
Apr 22, 2022
Buy
Common Stock
J-Other
Patel Nilesh Umedbhai
Insider
Unknown 0
Value: $0
Apr 22, 2022
Buy
Common Stock
J-Other
Patel Nilesh Umedbhai
Director 0
Value: $0
Apr 22, 2022
Buy
Common Stock
J-Other
Patel Nilesh Umedbhai
Insider
Unknown 0
Value: $0
Apr 22, 2022
Buy
Common Stock
J-Other
Patel Nilesh Umedbhai
Director 0
Value: $0
Mar 17, 2022
Buy
Stock Options (right to buy)
A-Award
Ross Harrison
Vice President Of Finance
CEO / President 273 750
Value: $24.6K
Mar 17, 2022
Buy
Stock Options (right to buy)
A-Award
Ross Harrison
Vice President Of Finance
CEO / President 273 750
Value: $24.6K
Mar 17, 2022
Buy
Stock Options (right to buy)
A-Award
Kovalyov Georgiy
Chief Financial Officer
C-Suite Officer 273 750
Value: $24.6K
Mar 17, 2022
Buy
Stock Options (right to buy)
A-Award
Kovalyov Georgiy
Chief Financial Officer
C-Suite Officer 273 750
Value: $24.6K
Feb 08, 2022
Sell
Stock Options (right to buy)
D-Return
Barthel David
Chief Executive Officer
CEO / President 400 000
Value: $900.0K
Feb 08, 2022
Buy
Stock Options (right to buy)
A-Award
Barthel David
Chief Executive Officer
CEO / President 400 000
Value: $700.0K
Feb 08, 2022
Buy
Stock Options (right to buy)
A-Award
Barthel David
Chief Executive Officer
CEO / President 400 000
Value: $700.0K
Feb 08, 2022
Sell
Stock Options (right to buy)
D-Return
Barthel David
Chief Executive Officer
CEO / President 400 000
Value: $900.0K
Dec 21, 2021
Buy
Common Stock
Ross Harrison
Vice President Of Finance
CEO / President 0
Value: $0
Dec 21, 2021
Buy
Warrants (Right to Buy)
Ross Harrison
Vice President Of Finance
CEO / President 100 000
Value: $126.0K
Dec 21, 2021
Buy
Consultant Stock Option (Right to Buy)
Ross Harrison
Vice President Of Finance
CEO / President 200 000
Value: $350.0K
Dec 21, 2021
Buy
Warrants (Right to Buy)
Kovalyov Georgiy
Chief Financial Officer
C-Suite Officer 100 000
Value: $126.0K
Dec 21, 2021
Buy
Consultant Stock Option (Right to Buy)
Kovalyov Georgiy
Chief Financial Officer
C-Suite Officer 200 000
Value: $350.0K
Dec 21, 2021
Buy
Common Stock
Kovalyov Georgiy
Chief Financial Officer
C-Suite Officer 0
Value: $0
Dec 21, 2021
Buy
Common Stock
Kovalyov Georgiy
Chief Financial Officer
C-Suite Officer 0
Value: $0
Dec 21, 2021
Buy
Consultant Stock Option (Right to Buy)
Kovalyov Georgiy
Chief Financial Officer
C-Suite Officer 200 000
Value: $350.0K
Dec 21, 2021
Buy
Warrants (Right to Buy)
Kovalyov Georgiy
Chief Financial Officer
C-Suite Officer 100 000
Value: $126.0K
Dec 21, 2021
Buy
Common Stock
Ross Harrison
Vice President Of Finance
CEO / President 0
Value: $0
Dec 21, 2021
Buy
Consultant Stock Option (Right to Buy)
Ross Harrison
Vice President Of Finance
CEO / President 200 000
Value: $350.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MARIZYME, INC.
Marizyme
Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and bur...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE